218 related articles for article (PubMed ID: 32669614)
1. The HNRNPA2B1-MST1R-Akt axis contributes to epithelial-to-mesenchymal transition in head and neck cancer.
Gupta A; Yadav S; Pt A; Mishra J; Samaiya A; Panday RK; Shukla S
Lab Invest; 2020 Dec; 100(12):1589-1601. PubMed ID: 32669614
[TBL] [Abstract][Full Text] [Related]
2. Recepteur d'origine nantais contributes to the development of endometriosis via promoting epithelial-mesenchymal transition of a endometrial epithelial cells.
Yu Q; Wang J; Li T; Guo X; Ding S; Che X; Zhu L; Peng Y; Xu X; Zou G; Zhang X
J Cell Mol Med; 2021 Feb; 25(3):1601-1612. PubMed ID: 33410267
[TBL] [Abstract][Full Text] [Related]
3. HnRNP A1 controls a splicing regulatory circuit promoting mesenchymal-to-epithelial transition.
Bonomi S; di Matteo A; Buratti E; Cabianca DS; Baralle FE; Ghigna C; Biamonti G
Nucleic Acids Res; 2013 Oct; 41(18):8665-79. PubMed ID: 23863836
[TBL] [Abstract][Full Text] [Related]
4. Alterations in a defined extracellular region of the RON receptor tyrosine kinase promote RON-mediated motile and invasive phenotypes in epithelial cells.
Zhang K; Zhou YQ; Yao HP; Wang MH
Int J Oncol; 2010 Jan; 36(1):255-64. PubMed ID: 19956854
[TBL] [Abstract][Full Text] [Related]
5. RON alternative splicing regulation in primary ovarian cancer.
Mayer S; Hirschfeld M; Jaeger M; Pies S; Iborra S; Erbes T; Stickeler E
Oncol Rep; 2015 Jul; 34(1):423-30. PubMed ID: 25997828
[TBL] [Abstract][Full Text] [Related]
6. Splicing factor hnRNP A2/B1 regulates tumor suppressor gene splicing and is an oncogenic driver in glioblastoma.
Golan-Gerstl R; Cohen M; Shilo A; Suh SS; Bakàcs A; Coppola L; Karni R
Cancer Res; 2011 Jul; 71(13):4464-72. PubMed ID: 21586613
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow mesenchymal stem cells promote head and neck cancer progression through Periostin-mediated phosphoinositide 3-kinase/Akt/mammalian target of rapamycin.
Liu C; Feng X; Wang B; Wang X; Wang C; Yu M; Cao G; Wang H
Cancer Sci; 2018 Mar; 109(3):688-698. PubMed ID: 29284199
[TBL] [Abstract][Full Text] [Related]
8. Ribonucleoprotein HNRNPA2B1 interacts with and regulates oncogenic KRAS in pancreatic ductal adenocarcinoma cells.
Barceló C; Etchin J; Mansour MR; Sanda T; Ginesta MM; Sanchez-Arévalo Lobo VJ; Real FX; Capellà G; Estanyol JM; Jaumot M; Look AT; Agell N
Gastroenterology; 2014 Oct; 147(4):882-892.e8. PubMed ID: 24998203
[TBL] [Abstract][Full Text] [Related]
9. Axl mediates acquired resistance of head and neck cancer cells to the epidermal growth factor receptor inhibitor erlotinib.
Giles KM; Kalinowski FC; Candy PA; Epis MR; Zhang PM; Redfern AD; Stuart LM; Goodall GJ; Leedman PJ
Mol Cancer Ther; 2013 Nov; 12(11):2541-58. PubMed ID: 24026012
[TBL] [Abstract][Full Text] [Related]
10. Dietary-phytochemical mediated reversion of cancer-specific splicing inhibits Warburg effect in head and neck cancer.
Yadav S; Bhagat SD; Gupta A; Samaiya A; Srivastava A; Shukla S
BMC Cancer; 2019 Nov; 19(1):1031. PubMed ID: 31675998
[TBL] [Abstract][Full Text] [Related]
11. Fyn requires HnRNPA2B1 and Sam68 to synergistically regulate apoptosis in pancreatic cancer.
Chen ZY; Cai L; Zhu J; Chen M; Chen J; Li ZH; Liu XD; Wang SG; Bie P; Jiang P; Dong JH; Li XW
Carcinogenesis; 2011 Oct; 32(10):1419-26. PubMed ID: 21642356
[TBL] [Abstract][Full Text] [Related]
12. RON Receptor Tyrosine Kinase Regulates Epithelial Mesenchymal Transition and the Expression of Pro-Fibrotic Markers via Src/Smad Signaling in HK-2 and NRK49F Cells.
Park JS; Choi HI; Kim DH; Kim CS; Bae EH; Ma SK; Kim SW
Int J Mol Sci; 2019 Nov; 20(21):. PubMed ID: 31690042
[TBL] [Abstract][Full Text] [Related]
13. MCP1-Induced Epithelial-Mesenchymal Transition in Head and Neck Cancer by AKT Activation.
Lee CC; Ho HC; Su YC; Lee MS; Hung SK; Lin CH
Anticancer Res; 2015 Jun; 35(6):3299-306. PubMed ID: 26026089
[TBL] [Abstract][Full Text] [Related]
14. Decoding a cancer-relevant splicing decision in the RON proto-oncogene using high-throughput mutagenesis.
Braun S; Enculescu M; Setty ST; Cortés-López M; de Almeida BP; Sutandy FXR; Schulz L; Busch A; Seiler M; Ebersberger S; Barbosa-Morais NL; Legewie S; König J; Zarnack K
Nat Commun; 2018 Aug; 9(1):3315. PubMed ID: 30120239
[TBL] [Abstract][Full Text] [Related]
15. Comparative secretome analysis of epithelial and mesenchymal subpopulations of head and neck squamous cell carcinoma identifies S100A4 as a potential therapeutic target.
Rasanen K; Sriswasdi S; Valiga A; Tang HY; Zhang G; Perego M; Somasundaram R; Li L; Speicher K; Klein-Szanto AJ; Basu D; Rustgi AK; Speicher DW; Herlyn M
Mol Cell Proteomics; 2013 Dec; 12(12):3778-92. PubMed ID: 24037664
[TBL] [Abstract][Full Text] [Related]
16. Salinomycin induces cell death and differentiation in head and neck squamous cell carcinoma stem cells despite activation of epithelial-mesenchymal transition and Akt.
Kuo SZ; Blair KJ; Rahimy E; Kiang A; Abhold E; Fan JB; Wang-Rodriguez J; Altuna X; Ongkeko WM
BMC Cancer; 2012 Nov; 12():556. PubMed ID: 23176396
[TBL] [Abstract][Full Text] [Related]
17. A novel protein isoform of the RON tyrosine kinase receptor transforms human pancreatic duct epithelial cells.
Chakedis J; French R; Babicky M; Jaquish D; Howard H; Mose E; Lam R; Holman P; Miyamoto J; Walterscheid Z; Lowy AM
Oncogene; 2016 Jun; 35(25):3249-59. PubMed ID: 26477314
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA H19 promotes colorectal cancer metastasis via binding to hnRNPA2B1.
Zhang Y; Huang W; Yuan Y; Li J; Wu J; Yu J; He Y; Wei Z; Zhang C
J Exp Clin Cancer Res; 2020 Jul; 39(1):141. PubMed ID: 32698890
[TBL] [Abstract][Full Text] [Related]
19. A novel RON splice variant lacking exon 2 activates the PI3K/AKT pathway via PTEN phosphorylation in colorectal carcinoma cells.
Ling Y; Kuang Y; Chen LL; Lao WF; Zhu YR; Wang LQ; Wang D
Oncotarget; 2017 Jun; 8(24):39101-39116. PubMed ID: 28388571
[TBL] [Abstract][Full Text] [Related]
20. Neuropilin-2 acts a critical determinant for epithelial-to-mesenchymal transition and aggressive behaviors of human head and neck cancer.
Ahn MH; Kim JH; Choi SJ; Kim HJ; Park DG; Oh KY; Yoon HJ; Hong SD; Lee JI; Shin JA; Cho SD
Cell Oncol (Dordr); 2024 Apr; 47(2):497-511. PubMed ID: 37787967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
